Back
Innovent Biologics Vs. CASI Pharmaceuticals Industry Stock Comparison
Sell
28
IVBIY
Innovent Biologics
Last Price:
19.15
Seasonality Move:
-2.14%
Sell
21
CASI
CASI Pharmaceuticals
Last Price:
3.17
Seasonality Move:
4.53%
Sell
28
Innovent Biologics (IVBIY)
is a Sell
Is Innovent Biologics a Buy, Sell or Hold?
- The current Innovent Biologics [IVBIY] share price is $19.15. The Score for IVBIY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- IVBIY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
21
CASI Pharmaceuticals (CASI)
is a Sell
Is CASI Pharmaceuticals a Buy, Sell or Hold?
- The current CASI Pharmaceuticals [CASI] share price is $3.11. The Score for CASI is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- CASI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IVBIY Stock Price Chart
What is Innovent Biologics's stock price today?
-
The Innovent Biologics share price today is $19.15
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IVBIY is experiencing slight buying pressure.
CASI Stock Price Chart
What is CASI Pharmaceuticals's stock price today?
-
The CASI Pharmaceuticals share price today is $3.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CASI is experiencing selling pressure, which indicates risk of future bearish movement.
IVBIY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 0.69 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.81 - 21.55) | Sell |
Bollinger Bands (100): | (20.03 - 22.27) | Sell |
CASI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 33.37 | Sell |
Chaikin Money Flow: | -44072 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.42 - 5.4) | Sell |
Bollinger Bands (100): | (4.76 - 6.88) | Sell |
IVBIY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.15 | Sell |
20-day SMA: | 19.72 | Sell |
50-day SMA: | 21.09 | Sell |
200-day SMA: | 20.28 | Sell |
8-day EMA: | 19.2 | Sell |
20-day EMA: | 19.72 | Sell |
50-day EMA: | 20.56 | Sell |
200-day EMA: | 20.17 | Sell |
CASI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.31 | Sell |
20-day SMA: | 4.1 | Sell |
50-day SMA: | 5.11 | Sell |
200-day SMA: | 4.81 | Sell |
8-day EMA: | 3.38 | Sell |
20-day EMA: | 3.98 | Sell |
50-day EMA: | 4.81 | Sell |
200-day EMA: | 5.05 | Sell |
Innovent Biologics Earnings Growth & IVBIY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CASI Pharmaceuticals Earnings Growth & CASI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.93 per share, and an increase next year of $0.34 per share.
Innovent Biologics Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CASI Pharmaceuticals Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |